Nasdaq TradeTalks: Pharma’s Untapped Profit Source

HEALTHPRIZE BLOG

HealthPrize CEO Tom Kottler recently spoke with Jill Malandrino, host of Nasdaq’s Trade Talks, about why pharma should look to medication adherence as its new profit source. Watch the video from Nasdaq TV below:

Want to learn more about the HealthPrize digital patient adherence and engagement platform? Request an online or in-person demo.